Nicotine Polacrilex
NDC 45802-873, Nicotine Polacrilex, lozenge, from Padagis Israel Pharmaceuticals Ltd.
- Product NDC
- 45802-873
- Status
- Listed
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Dosage form
- LOZENGE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA077007
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/45802-873 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NICOTINE4 mg/1
Pharmacologic classes
Cholinergic Nicotinic Agonist [EPC]; Nicotine [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 45802-873-05 | 45802087305 | 3 CONTAINER in 1 CARTON (45802-873-05) / 24 LOZENGE in 1 CONTAINER (45802-873-03) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
NADAC price for package 45802087305
GET /v1/drugs/nadac/45802087305
Use it
Look up 45802-873 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/45802-873 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 45802-873. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.